Compare SVRA & GIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVRA | GIII |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | 4500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2009 | 2006 |
| Metric | SVRA | GIII |
|---|---|---|
| Price | $4.71 | $28.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | $7.33 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 1.2M | 341.4K |
| Earning Date | 05-13-2026 | 06-05-2026 |
| Dividend Yield | N/A | ★ 1.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $2,957,012,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $430.87 | N/A |
| P/E Ratio | ★ N/A | $19.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $20.33 |
| 52 Week High | $7.01 | $34.83 |
| Indicator | SVRA | GIII |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 38.44 |
| Support Level | $3.36 | $28.28 |
| Resistance Level | $6.15 | $28.96 |
| Average True Range (ATR) | 0.27 | 1.02 |
| MACD | -0.03 | -0.39 |
| Stochastic Oscillator | 1.34 | 6.32 |
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.